On this episode Blake welcomes Greg Schiffman, Chief Financial Officer for Absci, the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. Greg discusses his career journey, the exciting growth from startup to IPO, and how SW Washington and Portland are positioned well to become a biotech hub.